Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
About this item
Full title
Author / Creator
Hao, Qian , Dai, Luyao , Chang, Lidan , Song, Dingli , Liu, Dandan , Ma, Xiaobin , Wu, Hao and Kang, Huafeng
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The role of neoadjuvant chemotherapy and its benefits in patients with triple-negative breast cancer (TNBC) and small tumors are unclear. This study aims to compare survival differences between clinical T1 TNBC receiving neoadjuvant chemotherapy (NAC) and adjuvant chemotherapy (AC). Data for patients with clinical T1 TNBC were extracted from the Su...
Alternative Titles
Full title
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f3a0093d04554d6b9e4a42f77aa917ef
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3a0093d04554d6b9e4a42f77aa917ef
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-68719-7
